跳至主要内容
临床试验/PACTR202607850859928
PACTR202607850859928进行中(未招募)4 期

Advancing pharmacy-based delivery of primary STI and HIV prevention for cisgender women

University of Washington International Clinical Research Center0 个研究点目标入组 720 人开始时间: 2026年10月5日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
720

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 17 Year(s)(—)
性别
Female

入选标准

  • Cis-gender female
  • Seeking contraception (emergency contraception, oral contraceptive pills, injectables, implants, and condoms) from the retail pharmacy site
  • Age = 15 and <25 years old
  • Willingness to receive PrEP screening per national guidelines including HIV testing
  • Not currently taking PrEP
  • Willing and eligible to take doxycycline
  • Planning to reside in the area for the next 12 months
  • Able and willing to provide informed consent for participation

排除标准

  • Current participation in other ongoing studies.
  • Medical contraindications to PrEP or doxycycline use (e.g., severe allergy to doxycycline, serious hepatic or renal disease).
  • Any other condition that, in the investigator’s judgment, would make participation unsafe or interfere with study procedures

研究者

发起方
University of Washington International Clinical Research Center

相似试验